Group One Trading’s Praxis Precision Medicines PRAX Stock Holding History

Group One Trading’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$368K	Buy	1,100 +600	+120%	+$190K	﹤0.01%	3788
2026 Q1	$161K	Sell	500 -15,700	-97%	-$4.86M	﹤0.01%	4297
2025 Q4	$4.77M	Sell	16,200 -4,400	-21%	-$819K	0.01%	1541
2025 Q3	$1.09M	Buy	20,600 +17,400	+544%	+$844K	﹤0.01%	2938
2025 Q2	$135K	Sell	3,200 -33,000	-91%	-$1.26M	﹤0.01%	4711
2025 Q1	$1.37M	Buy	36,200 +9,300	+35%	+$581K	﹤0.01%	2175
2024 Q4	$2.07M	Sell	26,900 -18,600	-41%	-$1.35M	﹤0.01%	1883
2024 Q3	$2.62M	Buy	+45,500	New	+$2.46M	0.01%	1508
2023 Q2	–	Sell	-2,940	Closed	-$35.7K	–	8093
2023 Q1	$35.7K	Buy	+2,940	New	+$124K	﹤0.01%	5110

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Group One Trading's PRAX Position: Q2 2026 in Review

Group One Trading increased its Praxis Precision Medicines (PRAX) stake by 1,191% in Q2 2026, buying an estimated $487K and bringing the position to 1,666 shares worth $558K. The position accounts for ﹤0.01% of the portfolio, ranked #3394.

Group One Trading first reported a position in PRAX in Q1 2022 and has held it in 14 quarters since. The position peaked at $3.5M in Q3 2024. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Group One Trading held 1,666 shares of Praxis Precision Medicines worth $558K as of Q2 2026.
Group One Trading bought 1,537 Praxis Precision Medicines shares in Q2 2026, an estimated $487K.
Praxis Precision Medicines made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3394 holding.
Group One Trading first reported a position in Praxis Precision Medicines in Q1 2022 and has held it in 14 quarters since.
Group One Trading's Praxis Precision Medicines position peaked at $3.5M in Q3 2024.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.